TrialPloS one2023

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.

Abbie Oey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.